Genetic pattern of SMN1, SMN2, and NAIP genes in prognosis of SMA patients

Egyptian Journal of Medical Human Genetics - Tập 21 Số 1 - 2020
Heba Hassan1, Maha S. Zaki2, Mahmoud Y. Issa2, Nagham ElBagoury1, Mona Essawi1
1Department of Medical Molecular Genetics, Human Genetics & Genome Research Division, National Research Centre, Cairo, 12311, Egypt
2Department of Clinical Genetics, Human Genetics & Genome Research Division, National Research Centre, Cairo, Egypt

Tóm tắt

Abstract Background Spinal muscular atrophy (SMA) is the most common autosomal recessive disorder in humans after cystic fibrosis. It is classified into five clinical grades based on age of onset and severity of the disease. Although SMN1 was identified as the SMA disease-determining gene, modifier genes mapped to 5q13 were affirmed to play a crucial role in determination of disease severity and used as a target for SMA therapy. In this study, we determined SMN2 copy number and NAIP deletion status in SMA Egyptian patients with different clinical phenotypes and had homozygous deletion of SMN1. We aimed at finding a prognostic genetic pattern including SMN1, SMN2, and NAIP gene genotypes to determine the clinical SMA type of the patient to help in genetic counseling and prenatal diagnosis. Results Copy number variations (CNVs) of exon 7 of SMN2 gene were significantly decreased with the increase in disease severity. Homozygous deletion of exon 5 of NAIP was detected in 60% (12/20) of type I SMA and in 73% (8/11) of type III SMA cases. Combining the data of the SMN2 and NAIP genes showed 8 genotypes. Patients with D2 genotype (0 copies of NAIP and 2 copies of SMN2) were likely to have type I SMA. Type II SMA patients mostly had no homozygous deletion of NAIP and 2 copies of SMN2. However, patients with N3 genotype (> 1 copy of NAIP and 3 copies of SMN2) and patients with D3 genotype (0 copies of NAIP and > 3 copies of SMN2) had type III SMA. Conclusion SMN2 and NAIP are the most important modifier genes whose copy numbers can affect the severity of SMA. We concluded that the combination of modifier genes to provide prognostic genetic pattern for phenotype determination is preferable than using CNVs of exon 7 of SMN2 gene only. CNVs of exon 7 of SMN2 are of high importance to predict patients’ response to genetic therapy. On the other hand, deletion of exon5 of NAIP gene alone is not a sufficient predictor of SMA severity.

Từ khóa


Tài liệu tham khảo

Ogino S, Wilson RB (2002) Genetic testing and risk assessment for spinal muscular atrophy (SMA). Hum Genet 111(6):477–500

Al Jumah M, Majumdar R, Rehana Z, Al Rajeh S, Eyaid W (2007) A pilot study of spinal muscular atrophy carrier screening in Saudi Arabia. J Pediatr Neurol 5(03):221–224

Hasanzad M, Azad M, Kahrizi K, Saffar BS, Nafisi S, Keyhanidoust Z et al (2010) Carrier frequency of SMA by quantitative analysis of the SMN1 deletion in the Iranian population. Eur J Neurol 17(1):160–162

Lyahyai J, Sbiti A, Barkat A, Ratbi I, Sefiani A (2012) Spinal muscular atrophy carrier frequency and estimated prevalence of the disease in Moroccan newborns. Genet Test Mol Biomarkers 16(3):215–218

Munsat TL, Davies KE (1992) International SMA consortium meeting. (26-28 June 1992, Bonn, Germany). Neuromuscul Disord 2(5–6):423–428

Russman BS (2007) Spinal muscular atrophy: clinical classification and disease heterogeneity. J Child Neurol 22(8):946–951

Roy N, McLean MD, Besner-Johnston A, Lefebvre C, Salih M, Carpten JD et al (1995) Refined physical map of the spinal muscular atrophy gene (SMA) region at 5q13 based on YAC and cosmid contiguous arrays. Genomics 26(3):451–460

Bürglen L, Lefebvre S, Clermont O, Burlet P, Viollet L, Cruaud C et al (1996) Structure and organization of the human survival motor neurone (SMN) gene. Genomics 32(3):479–482

Wirth B (2000) An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat 15(3):228–237

Cho S, Dreyfuss G (2010) A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity. Genes Dev 24(5):438–442

Anderson K, Talbot K (2003) Spinal muscular atrophies reveal motor neuron vulnerability to defects in ribonucleoprotein handling. Curr Opin Neurol 16(5):595–599

Essawi ML, Effat LK, Shanab GM, Al-Ettribi GM, El-Haronui AA, Karim AM (2007) Molecular analysis of SMN1 and NAIP genes in Egyptian patients with spinal muscular atrophy. Bratisl Lek Listy 108(3):133–137

Coovert DD, Le TT, McAndrew PE, Strasswimmer J, Crawford TO, Mendell JR et al (1997) The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 6(8):1205–1214

Monani UR, Sendtner M, Coovert DD, Parsons DW, Andreassi C, Le TT et al (2000) The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in SMN(−/−) mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet 9(3):333–339

Feldkötter M, Schwarzer V, Wirth R, Wienker TF, Wirth B (2002) Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 70(2):358–368

Zheleznyakova GY, Kiselev AV, Vakharlovsky VG, Rask-Andersen M, Chavan R, Egorova AA et al (2011) Genetic and expression studies of SMN2 gene in Russian patients with spinal muscular atrophy type II and III. BMC Med Genet 12:96

Y-j Q, X-s G, J-l B, Wang L-w, Y-y C, Lu Y-y et al (2015) Association of copy numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein gene with the natural history in a Chinese spinal muscular atrophy cohort. J Child Neurol 30(4):429–436

Scheffer H, Cobben JM, Matthijs G, Wirth B (2001) Best practice guidelines for molecular analysis in spinal muscular atrophy. Eur J Hum Genet 9(7):484–491

Wirth B, Brichta L, Schrank B, Lochmüller H, Blick S, Baasner A et al (2006) Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum Genet 119(4):422–428

Scharf JM, Endrizzi MG, Wetter A, Huang S, Thompson TG, Zerres K et al (1998) Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics. Nat Genet 20(1):83

Theodorou L, Nicolaou P, Koutsou P, Georghiou A, Anastasiadou V, Tanteles G et al (2015) Genetic findings of Cypriot spinal muscular atrophy patients. Neurol Sci 36(10):1829–1834

Calucho M, Bernal S, Alias L, March F, Vencesla A, Rodriguez-Alvarez FJ et al (2018) Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases. Neuromuscul Disord 28(3):208–215

Amara A, Adala L, Ben Charfeddine I, Mamai O, Mili A, Lazreg TB et al (2012) Correlation of SMN2, NAIP, p44, H4F5 and Occludin genes copy number with spinal muscular atrophy phenotype in Tunisian patients. Eur J Paediatr Neurol 16(2):167–174

Omrani O, Bonyadi M, Barzgar M (2009) Molecular analysis of the SMN and NAIP genes in Iranian spinal muscular atrophy patients. Pediatr Int 51(2):193–196

Samilchuk E, D'Souza B, Bastaki L, Al-Awadi S. Deletion analysis of the SMN and NAIP genes in Kuwaiti patients with spinal muscular atrophy. Hum Genet 1996;98(5):524–527

Watihayati MS, Zabidi-Hussin AM, Tang TH, Matsuo M, Nishio H, Zilfalil BA (2007) Deletion analyses of SMN1 and NAIP genes in Malaysian spinal muscular atrophy patients. Pediatr Int 49(1):11–14

Hahnen E, Forkert R, Marke C, Rudnik-Schoneborn S, Schonling J, Zerres K et al (1995) Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals. Hum Mol Genet 4(10):1927–1933

Tran VK, Sasongko TH, Hong DD, Hoan NT, Dung VC, Lee MJ et al (2008) SMN2 and NAIP gene dosages in Vietnamese patients with spinal muscular atrophy. Pediatr Int 50(3):346–351

Liang YH, Chen XL, Yu ZS, Chen CY, Bi S, Mao LG et al (2009) Deletion analysis of SMN1 and NAIP genes in southern Chinese children with spinal muscular atrophy. J Zhejiang Univ Sci B 10(1):29–34

Miskovic M, Lalic T, Radivojevic D, Cirkovic S, Vlahovic G, Zamurovic D et al (2011) Lower incidence of deletions in the survival of motor neuron gene and the neuronal apoptosis inhibitory protein gene in children with spinal muscular atrophy from Serbia. Tohoku J Exp Med 225(3):153–159

He J, Zhang Q-J, Lin Q-F, Chen Y-F, Lin X-Z, Lin M-T et al (2013) Molecular analysis of SMN1, SMN2, NAIP, GTF2H2, and H4F5 genes in 157 Chinese patients with spinal muscular atrophy. Gene. 518(2):325–329

Thông tin
Thông tin xuất bản

Egyptian Journal of Medical Human Genetics

Tập 21 Số 1

Thông tin tác giả